Eligibility criteria
Condition
Prophylaxis Of Invasive Fungal Infections
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- Patients with proven or probable IFI in previous 12 months receiving an allogenic stem
cell transplant for any haematological disease
Exclusion criteria
Show details
- Pregnant or lactating women
- Severe disease other tham the underlying condition
- Active, symptomatic uncontrolled Invasive Fungal Infection
- Any evidence of active fungal disease as defined by MSG-EORTC criteria
- Concomitant use of Voriconazole 36 hours before chemotherapy until 48 hours after
chemotherapy
- Other medical conditions, including HIV positive serology that would interfere with
the evaluation of therapeutic response or safety of study drug